XML 36 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Employee Stock and Benefit Plans
 12 Months Ended
Sep. 27, 2020
Share-based Payment Arrangement [Abstract]  
Employee Stock and Benefit Plans Employee Stock and Benefit Plans
We maintain several equity incentive plans under which we may grant non-qualified stock options, incentive stock options, restricted stock, restricted stock units (“RSUs”) or stock appreciation rights to employees, non-employee directors and consultants. We issue new shares of common stock upon exercise of stock options and the vesting of RSUs. We also have an employee stock purchase plan (“ESPP”).
As of September 27, 2020, there were 46.5 million shares of common stock available for issuance pursuant to future equity-based compensation awards and 11.9 million shares available for issuance under our ESPP.
Stock-based compensation expense recognized in the consolidated financial statements (in millions):
Fiscal Year EndedSep 27, 2020Sep 29, 2019Sep 30, 2018
Options$7.5 $20.0 $28.0 
RSUs241.0 288.0 222.3 
Total stock-based compensation expense recognized in the consolidated statements of earnings$248.5 $308.0 $250.3 
Total related tax benefit$47.8 $59.3 $62.4 
Total capitalized stock-based compensation included in net property, plant and equipment on the consolidated balance sheets$3.6 $3.4 $3.5 
Stock Option Plans
We provide stock options as a form of employee compensation, which are primarily time-vested. The majority of time-vested options become exercisable in four equal installments beginning a year from the grant date and generally expire 10 years from the grant date. Options granted to non-employee directors generally vest immediately or one year from grant. All outstanding stock options are non-qualified stock options.
The fair value of stock option awards was estimated at the grant date with the following weighted average assumptions for fiscal 2020, 2019 and 2018:
Stock Options
Granted During the Period
Fiscal Year Ended202020192018
Expected term (in years)7.84.13.6
Expected stock price volatility27.3 %21.6 %20.5 %
Risk-free interest rate1.2 %2.9 %2.1 %
Expected dividend yield2.9 %2.1 %2.2 %
Weighted average grant price$56.33 $67.33 $56.56 
Estimated fair value per option granted$11.30 $11.06 $7.32 
The expected term of the options represents the estimated period of time until exercise and is based on historical experience of similar awards, giving consideration to the contractual terms, vesting schedules and expectations of future employee behavior. Expected stock price volatility is based on a combination of historical volatility of our stock and the one-year implied volatility of Starbucks traded options, for the related vesting periods. The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent remaining term. The dividend yield assumption is based on our anticipated cash dividend payouts. The amounts shown above for the estimated fair value per option granted are before the estimated effect of forfeitures, which reduce the amount of expense recorded in the consolidated statements of earnings.
Stock option transactions for the year ended September 27, 2020 (in millions, except per share and contractual life amounts):
Shares
Subject to
Options		Weighted
Average
Exercise
Price
per Share		Weighted
Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
Outstanding, September 29, 201915.2 $49.45 5.0$592 
Granted0.1 56.33 
Exercised(6.0)43.92 
Expired/forfeited(0.1)52.20 
Outstanding, September 27, 20209.2 53.06 5.4287 
Exercisable, September 27, 20206.8 51.16 4.8226 
Vested and expected to vest, September 27, 20209.1 53.03 5.4286 
The aggregate intrinsic value in the table above, which is the amount by which the market value of the underlying stock exceeded the exercise price of outstanding options, is before applicable income taxes and represents the amount optionees would have realized if all in-the-money options had been exercised on the last business day of the period indicated.
As of September 27, 2020, total unrecognized stock-based compensation expense, net of estimated forfeitures, related to nonvested options was approximately $1 million, before income taxes, and is expected to be recognized over a weighted average period of approximately 1.0 year. The total intrinsic value of options exercised was $236 million, $466 million and
$236 million during fiscal 2020, 2019 and 2018, respectively. The total fair value of options vested was $25 million, $31 million and $53 million during fiscal 2020, 2019 and 2018, respectively.
RSUs
We have both time-vested and performance-based RSUs. Time-vested RSUs are awarded to eligible employees and entitle the grantee to receive shares of common stock at the end of a vesting period, subject solely to the employee’s continuing employment. The time-vested RSUs either vest in two or four equal annual installments beginning a year from the grant date. Our performance-based RSUs are awarded to eligible employees and entitle the grantee to receive shares of common stock if we achieve specified performance goals during the performance period and the grantee remains employed through the vesting period.
RSU transactions for the year ended September 27, 2020 (in millions, except per share and contractual life amounts):
Number
of
Shares		Weighted
Average
Grant Date
Fair Value
per Share		Weighted
Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
Nonvested, September 29, 20198.9 $62.56 1.1$788 
Granted4.0 81.96 
Vested(3.5)59.97 
Forfeited/canceled(1.1)71.88 
Nonvested, September 27, 20208.3 74.23 1.1699 
For fiscal 2019 and 2018, the weighted average fair value per RSU granted was $68.14 and $56.48, respectively. As of September 27, 2020, total unrecognized stock-based compensation expense related to nonvested RSUs, net of estimated forfeitures, was approximately $134 million, before income taxes, and is expected to be recognized over a weighted average period of approximately 1.9 years. The total fair value of RSUs vested was $211 million, $255 million and $166 million during fiscal 2020, 2019 and 2018, respectively.
ESPP
Our ESPP allows eligible employees to contribute up to 10% of their base earnings toward the quarterly purchase of our common stock, subject to an annual maximum dollar amount. The purchase price is 95% of the fair market value of the stock on the last business day of the quarterly offering period. The number of shares issued under our ESPP was 0.5 million in fiscal 2020.
Deferred Compensation Plan
We have a Deferred Compensation Plan for Non-Employee Directors under which non-employee directors may, for any fiscal year, irrevocably elect to defer receipt of shares of common stock the director would have received upon vesting of restricted stock units. The number of deferred shares outstanding related to deferrals made under this plan is not material.
Defined Contribution Plans
We maintain voluntary defined contribution plans, both qualified and non-qualified, covering eligible employees as defined in the plan documents. Participating employees may elect to defer and contribute a portion of their eligible compensation to the plans up to limits stated in the plan documents, not to exceed the dollar amounts set by applicable laws.
Our matching contributions to all U.S. and non-U.S. plans were $132.7 million, $122.1 million and $111.7 million in fiscal 2020, 2019 and 2018, respectively.